Clinical Trials

200 enrolled

Breast Neoplasms

NCT05325632 2026-03-02

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

53 enrolled

Breast Neoplasms

NCT05505643 2026-02-27

COOL-IT

120 enrolled

Breast Neoplasms

NCT07053085 2026-02-27

A Study of Surgery and Radiotherapy in People With Breast Cancer

162 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT02927912 2026-02-17

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

108 enrolled

Breast Neoplasms

NCT06291064 2026-02-17

TARMAC

85 enrolled

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT07217990 2026-02-17

NoCUT-BC

84 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02624973 2026-02-12

PETREMAC

200 enrolled

Phase NA Not yet recruiting

Breast Neoplasms

NCT07345026 2026-01-15

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

116 enrolled

Breast Neoplasms

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

120 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06092892 2025-12-10

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

45 enrolled

Breast Neoplasms, Lymphedema

NCT03546686 2025-10-27

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

80 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07169903 2025-09-12

STAR012

587 enrolled

Adenocarcinoma of Lung

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

30 enrolled

Carcinoma, Lobular

NCT01805076 2025-09-05

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Phase 3 Completed

317 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06839001 2025-06-26

CRYSTAL - SIX

Phase 3 Recruiting

750 enrolled

Breast Neoplasms

NCT06209099 2025-06-12

Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

96 enrolled

Rectal Neoplasms

NCT03612648 2025-03-24

Three Fraction Accelerated Partial Breast Irradiation as the Sole Method of Radiation Therapy for Low-risk Stage 0 and I Breast Carcinoma

77 enrolled

Breast Neoplasms

NCT00185744 2025-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

121 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Carcinoma, Ductal

NCT05545150 2025-02-07

Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study

113 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT02772731 2025-01-31

SHAVE2

Phase NA Completed

400 enrolled

Breast Neoplasms

NCT06496659 2024-11-14

SAINT

25 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06646770 2024-10-17

SELTIC

400 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06634966 2024-10-10

Segmentectomy for Solid-dominant Lung Cancer

Phase 3 Recruiting

277 enrolled

Adenocarcinoma of Lung

NCT04937283 2024-06-17

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

690 enrolled

Adenocarcinoma of Lung

NCT05717803 2024-06-03

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)

Phase 3 Recruiting

307 enrolled

Adenocarcinoma of Lung

NCT01618357 2024-05-22

Pre-Operative Radiation and Veliparib for Breast Cancer

Phase 1 Completed

19 enrolled

Breast Neoplasms

NCT06395337 2024-05-02

MIRCA & MIPAC

Phase 1/2 Unknown

20 enrolled

Phase NA Not yet recruiting

Pancreatic Neoplasms, Rectal Neoplasms

NCT06131632 2024-01-23

ConSIBreC

300 enrolled

Inflammatory Breast Neoplasms

NCT04805736 2024-01-05

Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer

Phase 2 Completed

60 enrolled

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT01980823 2023-08-30

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

23 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT05969847 2023-08-01

TRACE-LE

72 enrolled

Rectal Neoplasms

NCT05707767 2023-07-19

A Prospective Study of Surgical Treatment Strategies for Chordoma

100 enrolled

Sarcoma

Chordoma

NCT05772923 2023-03-17

OPAXX

168 enrolled

Rectal Neoplasms

NCT02400658 2023-01-25

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

358 enrolled

Breast Neoplasms

NCT02789657 2022-05-19

Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.

Phase 2 Completed

32 enrolled 10 charts

Breast Neoplasms

NCT04416685 2022-05-11

A New Anatomical Classification of Portal Vein Location of Pancreas Tumors

Phase NA Completed

43 enrolled

Pancreatic Neoplasms

NCT01234532 2022-05-03

0927GCC

5 enrolled 7 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04626986 2021-10-26

Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor

300 enrolled

Breast Neoplasms

NCT02907918 2021-09-29

PALTAN

26 enrolled 8 charts

Breast Neoplasms

NCT03437915 2021-03-09

351

Phase NA Withdrawn

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00574587 2020-10-14

Trial for Locally Advanced Breast Cancer Using Vorinostat Plus Chemotherapy

Phase 1/2 Completed

55 enrolled 10 charts

Breast Neoplasms

NCT02718365 2020-10-12

Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC

1,382 enrolled

Lung Neoplasms

NCT02462200 2020-06-25

SMART

81 enrolled

Breast Neoplasms

NCT03548844 2018-06-07

Local Excision Versus Total Mesorectal Excision In Pathological Complete Response (ypT0-1cN0) Mid- Or Low-Rectal Cancer After Neoadjuvant Therapy

326 enrolled

Rectal Neoplasms

NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Phase 2 Unknown

160 enrolled

Breast Neoplasms

NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

45 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT03038217 2017-02-03

Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer

Phase 3 Unknown

300 enrolled